Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (1478 total)
-
Creator: Fintzi J, Bonnett T, Sweeney DA, Huprikar NA, Ganesan A, Frank MG, McLellan SLF, Dodd LE, Tebas P, Mehta AK.
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-08-19
Description: The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) found that remdesivir therapy hastened recovery in patients hospitalized with COVID-19, but the pathway for this improvement was not explored. We investigated how the dynamics of clinical progression…Conservation strategies: This resource contains recommendations facilitating conservation of equipment and supplies during contingency (expected shortages) and crisis (known shortages) capacities and should not be applied as guidance when conventional capacities are available.
-
Creator: The Medical Letter on Drugs and Therapeutics
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-07-15
Description: COVID-19 Vaccine Comparison Chart (online only) effectiveness by vaccine and by variant. -
Creator: North Carolina Communicable Disease Manual
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2007-11
Description: NC Communicable Disease Manual/Case Definitions: MonkeypoxFrom: https://epi.dph.ncdhhs.gov/cd/lhds/manuals/cd/reportable_diseases.html -
Creator: CDC
Subject: Treatment & Care
Item Type: Hyperlink
Date Last Updated: 2019-10-08
Description: Information for clinicians related to Mpox:The first symptoms of mpox include fever, malaise, headache, and sometimes sore throat and cough. A distinguishing feature of mpox from smallpox is lymphadenopathy (swollen lymph nodes). This typically… -
Creator: the BATS Consortium
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-06-16
Description: Evidence is urgently needed to support treatment decisions for children with multisystem inflammatory syndrome (MIS-C) associated with severe acute respiratory syndrome coronavirus 2.Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Creator: the Overcoming COVID-19 Investigators
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-06-16
Description: The assessment of real-world effectiveness of immunomodulatory medications for multisystem inflammatory syndrome in children (MIS-C) may guide therapy. -
Creator: Emory
Subject: Treatment & Care
Item Type: Video
Date Last Updated: 2021-05-12
Description: Are vaccines safe for women who are pregnant? Hope to be pregnant? Join Emory infectious diseases and OB-GYN expert Dr. Denise Jamieson for a live discussion with Emory public health expert Dr. Jodie Guest -
Creator: NETEC
Subject: Treatment & Care
Item Type: Webinar
Date Last Updated: 2021-05-21
Description: Webinar slides attached.Objectives: Discuss the epidemiology, pathology, symptoms, and diagnosis of Long COVID Describe options for treatment support for Long COVID Explain how the members of the team can provide psychological support for Long COVID… -
Creator: Wiley, Z., K. Ross-Driscoll, Z. Wang, L. Smothers, A. K. Mehta, and R. E. Patzer.
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-04-02
Description: Since the introduction of remdesivir and dexamethasone for severe COVID-19 treatment, few large multi-hospital system US studies have described clinical characteristics and outcomes of minority COVID-19 patients who present to the emergency… -
Creator: Rosas, Ivan O., Norbert Bräu, Michael Waters, Ronaldo C. Go, Bradley D. Hunter, Sanjay Bhagani, Daniel Skiest, Mariam S. Aziz, Nichola Cooper, Ivor S. Douglas, Sinisa Savic, Taryn Youngstein, Lorenzo Del Sorbo, Antonio Cubillo Gracian, David J. De La…
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-04-22
Description: Coronavirus disease 2019 (Covid-19) is associated with immune dysregulation and hyperinflammation, including elevated interleukin-6 levels. The use of tocilizumab, a monoclonal antibody against the interleukin-6 receptor, has resulted in better…